200 related articles for article (PubMed ID: 33585249)
1. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
2. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
Zhou C; Zhao R; Zhao R; Wang A; Li W
Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study.
Li Z; Xu K; Tartarone A; Santarpia M; Zhu Y; Jiang G
Transl Lung Cancer Res; 2021 Feb; 10(2):995-1006. PubMed ID: 33718038
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer.
Chen X; Zhou F; Li X; Yang G; Zhao C; Li W; Wu F; Yu J; Gao G; Li J; Li A; Ren S; Zhou C
Ann Transl Med; 2020 May; 8(10):631. PubMed ID: 32566568
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
Front Oncol; 2022; 12():769203. PubMed ID: 35425708
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
8. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
Zhou Q; He Q; He W; Wang C; Liu G; Wang K; Li H; Li J; Xiao W; Fang Q; Peng L; Han Y; Wang D; Leng X
BMC Cancer; 2023 Nov; 23(1):1171. PubMed ID: 38037003
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of postoperative folate receptor-positive circulating tumor cells (FR + CTCs) for long-term prognosis in patients with invasive adenocarcinoma (IAC) of the lung.
Ma Z; Zhou Z; Wang S; Ji H; Zhao D; Wang L; Chen J
Thorac Cancer; 2024 May; 15(13):1060-1071. PubMed ID: 38532562
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
[No Abstract] [Full Text] [Related]
12. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
[TBL] [Abstract][Full Text] [Related]
13. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
14. Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I-IIIA NSCLC.
Garitaonaindia Y; Aguado-Noya R; Garcia-Grande A; Cordoba M; Coronado Albi MJ; Campo Cañaveral JL; Calvo V; Clemente MB; Álvarez R; Peñas M; Chara L; Royuela A; Provencio M
Transl Lung Cancer Res; 2023 Jul; 12(7):1414-1424. PubMed ID: 37577300
[TBL] [Abstract][Full Text] [Related]
15. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
16. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
Liu J; Han M; Huang H
Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
[TBL] [Abstract][Full Text] [Related]
17. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma.
Ma M; Xu S; Han B; He H; Ma X; Chen C
Ann Transl Med; 2022 Dec; 10(24):1339. PubMed ID: 36660706
[TBL] [Abstract][Full Text] [Related]
18. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter
Jin L; Fan WH; Luan Y; Wu M; Zhao W
PeerJ; 2021; 9():e11366. PubMed ID: 33987029
[TBL] [Abstract][Full Text] [Related]
20. Detection of PD‑L1 expression and epithelial‑mesenchymal transition of circulating tumor cells in non‑small cell lung cancer.
Jiang J; Mo W; Lian X; Cao D; Cheng H; Wang H
Exp Ther Med; 2024 Jul; 28(1):294. PubMed ID: 38827467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]